Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy

After introduction of levetiracetam (LEV), treatment of seizures in patients with malignant brain tumors has prominently improved. On the other hand, we still experience some cases with LEV-uncontrollable epilepsy. Perampanel (PER) is a noncompetitive α-amino-3-hydroxy-5-methyl-4-isoaxazolepropionat...

Descripción completa

Detalles Bibliográficos
Autores principales: CHONAN, Masashi, SAITO, Ryuta, KANAMORI, Masayuki, OSAWA, Shin-ichiro, WATANABE, Mika, SUZUKI, Hiroyoshi, NAKASATO, Nobukazu, TOMINAGA, Teiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970066/
https://www.ncbi.nlm.nih.gov/pubmed/31748440
http://dx.doi.org/10.2176/nmc.oa.2018-0245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970066/
https://www.ncbi.nlm.nih.gov/pubmed/31748440
http://dx.doi.org/10.2176/nmc.oa.2018-0245

Ejemplares similares